Literature DB >> 23278345

Cardiac characterization of 16 patients with large NF1 gene deletions.

R Nguyen1, T S Mir, L Kluwe, K Jett, M Kentsch, G Mueller, H Kehrer-Sawatzki, J M Friedman, V-F Mautner.   

Abstract

The aim of this study was to characterize cardiac features of patients with neurofibromatosis 1 (NF1) and large deletions of the NF1 gene region. The study participants were 16 patients with large NF1 deletions and 16 age- and sex-matched NF1 patients without such deletions. All the patients were comprehensively characterized clinically and by echocardiography. Six of 16 NF1 deletion patients but none of 16 non-deletion NF1 patients have major cardiac abnormalities (p = 0.041). Congenital heart defects (CHDs) include mitral insufficiency in two patients and ventricular septal defect, aortic stenosis, and aortic insufficiency in one patient each. Three deletion patients have hypertrophic cardiomyopathy. Two patients have intracardiac tumors. NF1 patients without large deletions have increased left ventricular (LV) diastolic posterior wall thickness (p < 0.001) and increased intraventricular diastolic septal thickness (p = 0.001) compared with a healthy reference population without NF1, suggestive of eccentric LV hypertrophy. CHDs and other cardiovascular anomalies are more frequent among patients with large NF1 deletion and may cause serious clinical complications. Eccentric LV hypertrophy may occur in NF1 patients without whole gene deletions, but the clinical significance of this finding is uncertain. All patients with clinical suspicion for NF1 should be referred to a cardiologist for evaluation and surveillance.
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NF1 microdeletion; cardiovascular disease; congenital heart disease; echocardiography; neurofibromatosis type 1

Mesh:

Year:  2012        PMID: 23278345     DOI: 10.1111/cge.12072

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  Triggering the succinate receptor GPR91 enhances pressure overload-induced right ventricular hypertrophy.

Authors:  Lei Yang; Di Yu; Huan-Huan Fan; Yu Feng; Liang Hu; Wei-Yan Zhang; Kai Zhou; Xu-Ming Mo
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation.

Authors:  Kitiwan Rojnueangnit; Jing Xie; Alicia Gomes; Angela Sharp; Tom Callens; Yunjia Chen; Ying Liu; Meagan Cochran; Mary-Alice Abbott; Joan Atkin; Dusica Babovic-Vuksanovic; Christopher P Barnett; Melissa Crenshaw; Dennis W Bartholomew; Lina Basel; Gary Bellus; Shay Ben-Shachar; Martin G Bialer; David Bick; Bruce Blumberg; Fanny Cortes; Karen L David; Anne Destree; Anna Duat-Rodriguez; Dawn Earl; Luis Escobar; Marthanda Eswara; Begona Ezquieta; Ian M Frayling; Moshe Frydman; Kathy Gardner; Karen W Gripp; Concepcion Hernández-Chico; Kurt Heyrman; Jennifer Ibrahim; Sandra Janssens; Beth A Keena; Isabel Llano-Rivas; Kathy Leppig; Marie McDonald; Vinod K Misra; Jennifer Mulbury; Vinodh Narayanan; Naama Orenstein; Patricia Galvin-Parton; Helio Pedro; Eniko K Pivnick; Cynthia M Powell; Linda Randolph; Salmo Raskin; Jordi Rosell; Karol Rubin; Margretta Seashore; Christian P Schaaf; Angela Scheuerle; Meredith Schultz; Elizabeth Schorry; Rhonda Schnur; Elizabeth Siqveland; Amanda Tkachuk; James Tonsgard; Meena Upadhyaya; Ishwar C Verma; Stephanie Wallace; Charles Williams; Elaine Zackai; Jonathan Zonana; Conxi Lazaro; Kathleen Claes; Bruce Korf; Yolanda Martin; Eric Legius; Ludwine Messiaen
Journal:  Hum Mutat       Date:  2015-08-21       Impact factor: 4.878

Review 3.  Emerging genotype-phenotype relationships in patients with large NF1 deletions.

Authors:  Hildegard Kehrer-Sawatzki; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2017-02-17       Impact factor: 4.132

4.  Prevalence, Type, and Molecular Spectrum of NF1 Mutations in Patients with Neurofibromatosis Type 1 and Congenital Heart Disease.

Authors:  Valentina Pinna; Paola Daniele; Giulio Calcagni; Lucio Mariniello; Roberta Criscione; Chiara Giardina; Francesca Romana Lepri; Hossein Hozhabri; Angela Alberico; Stefania Cavone; Annunziata Tina Morella; Roberta Mandile; Francesca Annunziata; Niccolò Di Giosaffatte; Maria Cecilia D'Asdia; Paolo Versacci; Rossella Capolino; Pietro Strisciuglio; Sandra Giustini; Daniela Melis; Maria Cristina Digilio; Marco Tartaglia; Bruno Marino; Alessandro De Luca
Journal:  Genes (Basel)       Date:  2019-09-04       Impact factor: 4.096

5.  Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.

Authors:  Lennart Well; Kimberly Döbel; Lan Kluwe; Peter Bannas; Said Farschtschi; Gerhard Adam; Victor-Felix Mautner; Johannes Salamon
Journal:  PLoS Genet       Date:  2021-05-05       Impact factor: 5.917

6.  Clinical characterization of children and adolescents with NF1 microdeletions.

Authors:  Hildegard Kehrer-Sawatzki; Lan Kluwe; Johannes Salamon; Lennart Well; Said Farschtschi; Thorsten Rosenbaum; Victor-Felix Mautner
Journal:  Childs Nerv Syst       Date:  2020-06-12       Impact factor: 1.475

7.  Intracardiac tumor as a rare manifestation of genetic syndromes-presentation of a family with Gorlin syndrome and a literature review.

Authors:  Krzysztof Szczałuba; Ewa Makuła; Anna Piórecka-Makuła; Justyna Sicińska; Małgorzata Rydzanicz; Piotr Gasperowicz; Rafał Płoski; Bożena Werner
Journal:  J Appl Genet       Date:  2020-09-22       Impact factor: 3.240

Review 8.  Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies.

Authors:  Manuel Ramos-Kuri; Sri Harika Meka; Fabio Salamanca-Buentello; Roger J Hajjar; Larissa Lipskaia; Elie R Chemaly
Journal:  Biol Res       Date:  2021-08-03       Impact factor: 5.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.